No Data
Acadia Signs Licensing Deal for Essential Tremor Drug Candidate
Acadia Pharmaceuticals Announces Exclusive License Agreement With Saniona For SAN711; Under The Terms Of The License Agreement, Saniona Will Receive $28M Upfront Plus Potential Milestone Payments Of Up To $582M
Exelixis Provides Regulatory Update Related To Supplemental New Drug Application For Cabozantinib; Alliance For Clinical Trials In Oncology Independent Data And Safety Monitoring Board Recommends Trial Enrollment To Be Stopped
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock